Rifaximin-d6 (Major) is a deuterated active pharmaceutical ingredient primarily used as an analytical standard or labeled compound for pharmaceutical research. Its structure contains multiple rings, including aromatic and heterocyclic systems, along with alcohol, amide, ester, and ether functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Rifaximin-d6 (Major)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Urapidil-d3 (methoxy-d3)
pharmaceutical raw material
Nicotinic-d4 Acid
pharmaceutical raw material
(+/-)-Ondansetron-d5 (methylimidazole-d5)
pharmaceutical raw material
(1S,3R,4S)-quinuclidin-3-yl (S)-1-(phenyl-d5)-3,4-dihydroisoquinoline-2(1H)-carboxylate
pharmaceutical raw material
Paromomycin sulfate
pharmaceutical raw material
Erythromycin ethylsuccinate
pharmaceutical raw material
Colistin sulfate
pharmaceutical raw material
Mupirocin
pharmaceutical raw material
[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-28,29,31-trideuterio-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-30-(trideuteriomethyl)-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate
NZCRJKRKKOLAOJ-JDVCSXHWSA-N
[2H]C1=C(N2C3=C(C4=C5C(=C(C6=C4C(=O)[C@](O6)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(=O)NC3=C5O)/C)C)O)C)O)C)OC(=O)C)C)OC)C)C)O)N=C2C(=C1C([2H])([2H])[2H])[2H])[2H]
Sourcing Rifaximin-d6 (Major)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.